Cargando…

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment

Tumor-adjacent normal (TAN) tissues, which constitute tumor microenvironment and are different from healthy tissues, provide critical information at molecular levels that can be used to differentiate aggressive tumors from indolent tumors. In this study, we analyzed 52 TAN samples from the Cancer Ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Rui, Feng, Yuanfa, Ye, Jianheng, Han, Zhaodong, Liang, Yuxiang, Chen, Qingbiao, Xu, Xiaoming, Huang, Yuhan, Jia, Zhenyu, Zhong, Weide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495167/ https://www.ncbi.nlm.nih.gov/pubmed/34631510 http://dx.doi.org/10.3389/fonc.2021.632571

Ejemplares similares

Preoperative Predictors of Biochemical Recurrence-Free Survival in High-Risk Prostate Cancer Following Radical Prostatectomy
por: Nkengurutse, Gerard, et al.
Publicado: (2020)

Characterization of 7-Methylguanosine Identified Biochemical Recurrence and Tumor Immune Microenvironment in Prostate Cancer
por: Xin, Sheng, et al.
Publicado: (2022)

TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma
por: Xu, Zijun, et al.
Publicado: (2021)

Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
por: Cai, Zhiduan, et al.
Publicado: (2020)

Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022)

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
por: Ye, Jianheng, et al.
Publicado: (2023)

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure
por: Katz, Alan, et al.
Publicado: (2016)

Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential
por: Zhang, Hui, et al.
Publicado: (2021)

Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer
por: Darwish, Oussama M., et al.
Publicado: (2012)

Advanced Imaging of Biochemical Recurrent Prostate Cancer With PET, MRI, and Radiomics
por: Shaikh, Faiq, et al.
Publicado: (2020)

Identification and validation of a signature involving voltage-gated chloride ion channel genes for prediction of prostate cancer recurrence
por: Luo, Yong, et al.
Publicado: (2022)

A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer
por: Ke, Zhi-Bin, et al.
Publicado: (2022)

Identification of tumor-agnostic biomarkers for predicting prostate cancer progression and biochemical recurrence
por: Lautert-Dutra, William, et al.
Publicado: (2023)

Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy
por: Zhong, Qiu-Zi, et al.
Publicado: (2020)

Gene signatures predict biochemical recurrence‐free survival in primary prostate cancer patients after radical therapy
por: Su, Qiang, et al.
Publicado: (2021)

FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer
por: Yu, Zhaojun, et al.
Publicado: (2023)

Construction of DNA methylation-based nomogram for predicting biochemical-recurrence-free survival in prostate cancer
por: Zhu, Jiayu, et al.
Publicado: (2022)

A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma
por: Zhang, Shu-Wen, et al.
Publicado: (2022)

Statin Use and the Risk of Prostate Cancer Biochemical Recurrence Following Definitive Therapy: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sun, Jian-Xuan, et al.
Publicado: (2022)

COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival
por: Ren, Xiaohan, et al.
Publicado: (2021)

Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer
por: Wei, Jingchao, et al.
Publicado: (2022)

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2023)

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
por: Lu, Jianming, et al.
Publicado: (2023)

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
por: Zou, Zhihao, et al.
Publicado: (2021)

A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
por: Zhang, Zehan, et al.
Publicado: (2022)

A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer
por: Feng, Dechao, et al.
Publicado: (2022)

Biochemical recurrence-free survival and pathological outcomes after radical prostatectomy for high-risk prostate cancer
por: Beauval, Jean-Baptiste, et al.
Publicado: (2016)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
por: Park, Sung-Woo, et al.
Publicado: (2020)

The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders
por: Cai, Shanghua, et al.
Publicado: (2021)

Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancer
por: Qin, Guo-qiang, et al.
Publicado: (2014)

Adjuvant TACE may not improve recurrence-free or overall survival in HCC patients with low risk of recurrence after hepatectomy
por: Feng, Long-Hai, et al.
Publicado: (2023)

Diagnostic performance of 99mTc-HYNIC-PSMA SPECT/CT for biochemically recurrent prostate cancer after radical prostatectomy
por: Li, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1qinlids4vhdus5sajuo42drjs